company

VIVI IRENE HANSENS FOND TIL FORSKNING AV SYKDOMMEN LUPUS ERYTHEMATOSUS DISSEMINATUS

Return on Equity
−15,02 %
Current Ratio
902,5
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue−4 816 000
Net Income−5 418 000
Total Assets36 100 000
Total Equity36 060 000
Income (NOK)2022
Revenue−4 816 000
Expenditure101 000
Operating Profit−4 918 000
Financial Income0
Financial Costs500 000
Financial Balance−500 000
Earnings Before Tax−5 418 000
Tax0
Net Income−5 418 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets36 100 000
Total Assets36 100 000
Total Retained Equity30 412 000
Total Equity36 060 000
Total Long-Term Debt0
Total Current Debt40 000
Total Equity and Debt36 100 000
Cash flow (NOK)2022
Sales Income0
Other Income−4 816 000
Revenue−4 816 000
Cost of Goods Sold0
Salary Costs94 000
Depreciation0
Impairment0
Expenditure101 000
Operating Profit−4 918 000
Financial Income0
Financial Costs500 000
Financial Balance−500 000
Dividends0
Net Income−5 418 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments35 375 000
Cash, Bank724 000
Total Current Assets36 100 000
Total Assets36 100 000
Total Equity36 060 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt40 000
Total Current Debt40 000
Total Equity and Debt36 100 000
Financial indicators2022
Return on Equity−15,02 %
Debt-to-Equity Ratio0
Operating Profit Margin102,12 %
Current Ratio902,5
Quick Ratio902,5
Equity Ratio1
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English